Galapagos NV
GLPG
#4558
Rank
ยฃ1.67 B
Marketcap
ยฃ25.09
Share price
-1.20%
Change (1 day)
18.68%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -ยฃ0.18

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -ยฃ0.25. In 2024 the company made an earnings per share (EPS) of ยฃ0.87 a decrease over its 2023 EPS that were of ยฃ2.64.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.18-121.12%
2024ยฃ0.87-67.16%
2023ยฃ2.64-199.64%
2022-ยฃ2.6599.03%
2021-ยฃ1.33-68.98%
2020-ยฃ4.29-298.06%
2019ยฃ2.16-554.64%
2018-ยฃ0.48-77.18%
2017-ยฃ2.09-326.21%
2016ยฃ0.92-134.19%
2015-ยฃ2.70-371.34%
2014ยฃ0.99-445.98%
2013-ยฃ0.2932.88%
2012-ยฃ0.22-82.07%
2011-ยฃ1.21-817.9%
2010ยฃ0.1712.73%
2009ยฃ0.15-120.79%
2008-ยฃ0.72-37.67%
2007-ยฃ1.1539.64%
2006-ยฃ0.8228.17%
2005-ยฃ0.646.25%
2004-ยฃ0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.27-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.79-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.78-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.53-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ5.43-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ3.97-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.80-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ0.45 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.92-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel